drugset / Trial / NCT01669434

Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery

NCT01669434

Phase 4 Completed 291 enrolled University of Nebraska
RandomizedParallel-groupOpen-labelTreatment

Summary

Primary research hypothesis: Patients who continue their chronic ACEI therapy up to and including the morning of a non-cardiac, non-vascular surgery will experience more intraoperative hypotension than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #1: Patients who continue their chronic ACEI up to and including the morning of a non-cardiac, non-vascular surgery will experience better postoperative control of hypertension than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #2: Patients who continue their chronic ACEI up to and including the morning of a non-cardiac, non-vascular surgery will experience less acute renal failure than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #3: In the subgroup of patients with a preoperative systolic blood pressure less than 110 mmHg, those who continue their chronic ACEI therapy up to and including the morning of a non-cardiac, non-vascular surgery will experience more intraoperative hypotension than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #4: In the subgroup of patients above the age of 64, those who continue their chronic ACEI therapy up to and including the morning of a non-cardiac, non-vascular surgery will experience more intraoperative hypotension than those who transiently hold their chronic ACEI preoperatively.

Timeline

Start
2015-06-01
Primary completion
2016-11-01
Completion
2016-12-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Benazepril Unknown
Subject Captopril Small molecule
Subject Enalapril Other / unclassified
Subject Fosinopril Small molecule
Subject LISINOPRIL ANHYDROUS Small molecule
Subject Moexipril Small molecule
Subject Perindopril Small molecule
Subject Quinapril Small molecule
Subject Ramipril Small molecule
Subject trandolapril Small molecule

Indications

No indication recorded.